Brief: Caredx And Miromatrix Announce Exclusive Partnership To Advance Research Using Bioengineered Organs For Human Transplantation
April 5 (Reuters) - CareDx Inc CDNA.O :
* CAREDX AND MIROMATRIX ANNOUNCE EXCLUSIVE PARTNERSHIP TO
ADVANCE
RESEARCH USING BIOENGINEERED ORGANS FOR HUMAN TRANSPLANTATION
* CAREDX INC - CAREDX EXCLUSIVE PROVIDER OF DD-CFDNA TESTING
SERVICES FOR USE IN MIROMATRIX CLINICAL TRIALS
Source text for Eikon: ID:nGNXc1jQG7
Further company coverage: CDNA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Miromatrix Medical
See all newsU.S. STOCKS ON THE MOVE-SeaStar, SJW Group, Pinterest
U.S. STOCKS ON THE MOVE-Crypto, Miromatrix Medical, US banks
U.S. STOCKS ON THE MOVE-JinkoSolar, Reviva, MeiraGTx
U.S. STOCKS ON THE MOVE-McDonald, Coherus BioSciences, Miromatrix,
Brief: Miromatrix To Pay United Therapeutics Termination Fee Of $4 Million In Connection With Termination Of Merger